Sustained impact of anticoagulant control achieved in an anticoagulation management service after transfer of management to the primary care physician

Pharmacotherapy

Volumn 32, Issue 2, 2012, Pages 112-119

  Bungard, Tammy J ^a,c   Ritchie, Bruce ^b   Garg, Sipi ^c   Tsuyuki, Ross T ^a,c  

^a Division of Cardiology   (Canada)

^b Divisions of Hematology   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

AMS; Anticoagulants; Anticoagulation management service; Health services research; Outcomes research; Pharmacist management; Quality of care

Indexed keywords

WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CONTROLLED STUDY; DRUG INDICATION; FEMALE; GENERAL PRACTITIONER; HEALTH CARE QUALITY; HEALTH SERVICE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT CARE; PATIENT PREFERENCE; PATIENT SATISFACTION; PATIENT SELECTION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; THROMBOSIS; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANTICOAGULANTS; CARDIOVASCULAR DISEASES; DISEASE MANAGEMENT; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PHYSICIANS, PRIMARY CARE; PROSPECTIVE STUDIES;

EID: 84864578646     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1002/PHAR.1011     Document Type: Article

References (18)

1. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of vitamin K antagonists: Amercian College of Chest Physicians evidence-based clinical practice guidelines. Chest 2008;133:S160-98.
2. Garcia DA, Witt DM, Hylek E, et al. Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation Forum. Ann Pharmacother 2008;42:979-88.
3. Witt DM, Sadler MA, Shanahan RL, Shanahan RL, Mazzoli G, Tillman DJ. Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy. Chest 2005;127:1515-22.
4. Bungard TJ, Gardner L, Archer S, et al. Evaluation of a pharmacist- managed anticoagulation clinic: improving patient care. Open Med 2009;3:e16-21.
5. Bungard TJ, Archer SL, Hamilton P, Ritchie B, Tymchak W, Tsuyuki RT. Bringing the benefits of anticoagulation management services to the community: Alberta program may serve as a model of care. CPJ 2006;139:58-63.
6. Bungard TJ, Grant CM, Ackman ML, Tsuyuki RT. Anticoagulation clinics in North America: operational insights. Can J Hosp Pharm 2008;61:249-55.
7. Garwood CL, Dumo P, Baringhaus SN, Laban KM. Quality of anticoagulation care in patients discharged from a pharmacistmanaged anticoagulation clinic after stabilization of warfarin therapy. Pharmacotherapy 2008;28:20-6.
8. Samsa G, Matchar DB, Dolor RJ, et al. A new instrument for measuring anticoagulation-related quality of life: development and preliminary validation [online exclusive article]. Health Qual Life Outcomes 2004;2:22. Available from http://www. hqlo.com/content/2/1/22.
9. Rosendall FR, Cannegieter SC, Van der Meer FJ, Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993;69:236-9.
10. Bungard TJ, Ackman ML, Ho G, Tsuyuki RT. Adequacy of anticoagulation in patients coming to hospital with atrial fibrillation. Pharmacotherapy 2000;20:1060-5.
11. Nichol MB, Knight TK, Dow T, et al. Quality of anticoagulation monitoring in nonvalvular atrial fibrillation patients: comparison of anticoagulation clinic versus usual care. Ann Pharmacother 2008;42:62-70.
12. Menzin J, Boulanger L, Hauch O, et al. Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: a multi-site managed-care study. Ann Pharmacother 2005;39:446-51.
13. Wilson SJ, Wells PS, Kovacs MJ, et al. Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial. Can Med Assoc J 2003;169:293-8.
14. Staresinic AG, Sorkness CA, Goodman BM, Pigarelli DW. Comparison of outcomes using 2 delivery models of anticoagulation care. Arch Intern Med 2006;166:997-1002.
15. Amruso NA. Ability of clinical pharmacists in a community pharmacy setting to manage anticoagulation therapy. J Am Pharm Assoc 2004;44:467-71.
16. Ernst ME, Brandt KB. Evaluation of 4 years of clinical pharmacist anticoagulation case management in a rural, private physician office. J Am Pharm Assoc 2003;43:630-6.
17. Lewis SM, Kroner BA. Patient survey of a pharmacist-managed anticoagulation clinic. Manag Care Interface 1997;10:66-70.
18. Lodwick AD, Sajbel TA. Patient and physician satisfaction with a pharmacist-managed anticoagulation clinic: implications for managed care organizations. Manag Care 2000;9:47-50.